retatrutide clinical trial results obesity VisualAbstract: reduces body weight by 17.5% in patients with Retatrutide Shows 28% Weight Loss

7 In fact, previous studies have reported conflicting evidence regarding the impact of these novel medications on cancer incidence

Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial

These can include nausea, acid reflux, constipation or diarrhea, and rarely, a type of thyroid cancer called medullary thyroid cancer

Och, A., et al

Whether its used for EHR systems to enhance patient records, remote patient monitoring (RPM) platforms for real-time health tracking, or corporate wellness programs to boost engagement, FitXpress delivers data that empowers businesses to provide more targeted and effective health solutions